PAROMOMYCIN IS EFFECTIVE AS PROPHYLAXIS FOR CRYPTOSPORIDIOSIS IN DAIRY CALVES

被引:102
作者
FAYER, R
ELLIS, W
机构
[1] Experimental Therapeutics Division, Walter Reed Army Medical Center, Walter Reed Army Inst. of Research, Washington
关键词
D O I
10.2307/3283619
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Of 16 experimentally infected neonatal dairy calves. 12 were fed paromomycin twice daily in their milk for 11 consecutive days beginning 1 day before oral inoculation with 1.5-2.0 x 10(6) oocysts of Cryptosporidium parvum. Four calves each in groups A, B, C, and D received total daily doses of 100. 50, 25, and 0 mg of paromomycin per kilogram of body weight, respectively. From birth until 28 days of age feces from each calf were examined for diarrhea, and oocysts were enumerated, rectal temperature was recorded, and weight gain was determined. Total days of diarrhea, severity of diarrhea, the total number of days oocysts were shed, and the number of oocysts shed were significantly less in group A than in the un medicated group D. The severity of diarrhea was also significantly less in groups B and C than in group D. Oocysts were not detected in feces from calves in group A. Except for 1 calf, oocysts were not detected from calves in groups B and C during the first week the drug was administered and those calves that shed oocysts began shedding at or near the end of paromomycin administration or more than 1 wk after treatment ended. Frequency of fever and weight gains did not vary significantly between the unmedicated and medicated groups except for group C, calves of which gained significantly less weight than those in all other groups.
引用
收藏
页码:771 / 774
页数:4
相关论文
共 11 条
[1]  
Angus K.W., 1990, P83
[2]   TREATMENT OF CRYPTOSPORIDIOSIS WITH PAROMOMYCIN - A REPORT OF 5 CASES [J].
ARMITAGE, K ;
FLANIGAN, T ;
CAREY, J ;
FRANK, I ;
MACGREGOR, RR ;
ROSS, P ;
GOODGAME, R ;
TURNER, J .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (12) :2497-2499
[3]  
BARR SC, 1993, IN PRESS J AM VET ME
[4]  
CLEZY K, 1991, AIDS, V5, P1146, DOI 10.1097/00002030-199109000-00020
[5]  
Current W.L., 1990, P31
[6]  
Fayer R., 1990, P1
[7]   GLYCOSIDE ANTIBIOTICS ALONE AND COMBINED WITH TETRACYCLINES FOR PROPHYLAXIS OF EXPERIMENTAL CRYPTOSPORIDIOSIS IN NEONATAL BALB/C MICE [J].
FAYER, R ;
ELLIS, W .
JOURNAL OF PARASITOLOGY, 1993, 79 (04) :553-558
[8]   USE OF PAROMOMYCIN FOR TREATMENT OF CRYPTOSPORIDIOSIS IN PATIENTS WITH AIDS [J].
FICHTENBAUM, CJ ;
RITCHIE, DJ ;
POWDERLY, WG .
CLINICAL INFECTIOUS DISEASES, 1993, 16 (02) :298-300
[9]   PURIFICATION OF CRYPTOSPORIDIUM OOCYSTS AND SPOROZOITES BY CESIUM-CHLORIDE AND PERCOLL GRADIENTS [J].
KILANI, RT ;
SEKLA, L .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1987, 36 (03) :505-508
[10]   PAROMOMYCIN INHIBITS CRYPTOSPORIDIUM INFECTION OF A HUMAN ENTEROCYTE CELL-LINE [J].
MARSHALL, RJ ;
FLANIGAN, TP .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (04) :772-774